22 December 2014
Professor Draganski’s team analysed brains from people at risk of developing autism spectrum disorder and schizophrenia. This led to the discovery of a potential biomarker for preclinical use. Autism spectrum disorder, schizophrenia and obesity all have in common a ‘bad’ Read more…